Language selection

Search

Patent 2000348 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2000348
(54) English Title: TAMPER PROOF ENCAPSULATED MEDICAMENTS
(54) French Title: MEDICAMENTS ENCAPSULES INVIOLABLES
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 9/54 (2006.01)
(72) Inventors :
  • BARSHAY, STANLEY F. (United States of America)
  • MAYER, PETER (United States of America)
(73) Owners :
  • AMERICAN HOME PRODUCTS CORPORATION
(71) Applicants :
  • AMERICAN HOME PRODUCTS CORPORATION (United States of America)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1989-10-10
(41) Open to Public Inspection: 1991-04-10
Examination requested: 1996-08-30
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract


AEIP-8840
ABSTRACT
A tamper-proof capsule dosage form for pharmaceuticals having a
medicinal containing caplet adhesively bonded to the inner end surfaces of the
capsule such that upon tampering the capsule dosage form will be destroyed or
rendered non-reusable.


Claims

Note: Claims are shown in the official language in which they were submitted.


AHP-8840
-5-
THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A tamper-proof capsule dosage form containing a pharmaceutical
medicament for oral administration comprising:
a) an elongated essentially round hard gelatin capsule made in two
sections slip-fit joinable;
b) a solid caplet containing a medicament susbtance shaped and sized
closely to fit within the assembled capsule; and
c) a pharmaceutically acceptable adhesive situated between each caplet
end and the adjacent inner surface of the capsule.

Description

Note: Descriptions are shown in the official language in which they were submitted.


A~P-8840
,:
TAMPER PROOF ENCAPSULATED MEDICAM~NTS
Background Of The Invention
This invention related to a tamperproof capsule dosage form for
pharmaceutical preparations and more part;cularly to a hard gelatin eapsule
dosage form which will be destroyed if opened so that extraneous substances
cannot be inserted in the opened capsule and the capsule then re-closed.
The art is replete with systems for loclcing capsules containing
pharmaceutical preparations for oral administration. For example, sound waves
have been used to lock together the two pieces of hard gelatin shell after the
medicament has been enclosed within the capsule formed from the shells. In
another system, the larger half of the two-piece capsule fits almost completely
over the smaller half. In still another system, a gelatin band is applied to thefilled capsule and fused to hold the two capsule pieces together. Such systems
have been found to be lacking in adequate protection, however, since one or
several capsules can be opened and the components used to encapsulate an
: extraneous substance in capsule components closely resembling the original
medication.
mmar~ Of The ~vention
This invention comprises a tamper-proof capsule dosage form
containing a pharmaceutical medicament for oral administration which will be
destroyed ii opened prior to administrQtion. The temper-prooi oapsule dosege
~.:
``:
;

2()~ a~
AHP-8840
_~_
:
form comprises three basic components including a hard gelatin capsule, a
pharmaceutical medicament in caplet, i.e. elongated tablet shape, and an edible
adhesive, which components, when assembled hold each end of the caplet
adhesively bonded to the adjacent inside surface of the capsule.
Detailed Description Of lhe ~rention
The three basic components of the tamper-proof capsule dosage form of
the invention comprise:
` a) a hard gelatin capsule, well known in the art, such is marketed by
R.P. Seherer Corporation of Troy, New York, made in two pieces in whieh the
medicament, usually in powder or particlllate form, is placed in a first piece and
the other piece is then slip-fitted over and joined to the first piece;
b) a medicinal caplet for oral administration shaped and sized closely
to fit within the assembled capsule; and
;
` c) a pharmaceutically acceptable edible adhesive, the adhesive
bonding each end portion of the caplet to the adjacent inside surface of the
- capsule.
The hard gelatin capsule can be any size from 4 to 000 and preferably it
` should be a clear gelatin so the user can see the caplet inside and also extraneous
`` material, if any.
:.

4~
A~IP-8840
-3-
The caplet can contain any of the many medicinals presently
marketed over-the-counter or on a prescription basis such as aspirin,
acetaminophen and ibuprofen.
The edible adhesive can be a pharmaceutically acceptable water or
organic solvent soluble adhesive including a protein adhesive such as zein or
casein, a silieone adhesive, a plastic adhesive such as an acrylic polymer, shellac
or a cellulose. Also the adhesive can be a heat-sealable or an ultrasound-
sealable adhesive well known to the art.
The invention will now be described with reference to the
accompanying drawings whereino
; Figure 1 is an exploded view of the tamper-proof encapsulated dosage
form of the invention:
,
Figure 2 is a view of the assembled tamper-proof encapsulated
dosage form of the invention.
Figure 3 is a cross-sectional view along line 3-3, i.e. the elongated
axis of the tamper-proof encapsulated dosage Iorm of the invention; and
;~ Figure 4 is a cross-sectional view along line 4-4, i.e. around the
~. circumference of the encapsulated dosage form of the invention.
~ . ~
.:
, .
. .
. ~ ~
~ ' ~

A~{P-8840
--4--
Turning now to ~igures 1 through ~, the caplet 1 is sized closely to fit
into the capsule designated by its two components 2 and 3. The caplet mold can
be designed to provide sufficient tolerance sueh that there is sufficient space at
each end 4 and 5 of the caplet 1 and between the inside surfaces 6 and 7 of the
capsule ends 2 and 3 to receive a drop or two of adhesive designated 8 and 9
respectively.
The tamper-proof dosage form is assembled by placing the adhesive
on each end of the caplet or on the inner end surfaces of the capsule sections,
inserting the caplet into the section of the capsule smaller in diameter, then
slipping the section of the capsule larger in diameter over the exposed end of the
caplet and slip-fitting the two sections together to form the capsule.
.
- Any moisture or solvent in the adhesive will pass through the capsule
wall since the gelatin acts as a semi-permeable membrane. If too much moisture
is present in the adhesive, the capsule may become deformed, and hence it is
preferable to use low moisture content adhesives. Gentle warming of the filled
capsules will accelerate the drying of the adhesive.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Application Not Reinstated by Deadline 2000-01-31
Inactive: Dead - Final fee not paid 2000-01-31
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 1999-10-12
Deemed Abandoned - Conditions for Grant Determined Not Compliant 1999-02-01
Notice of Allowance is Issued 1998-07-31
Notice of Allowance is Issued 1998-07-31
Letter Sent 1998-07-31
Inactive: Application prosecuted on TS as of Log entry date 1998-07-27
Inactive: Status info is complete as of Log entry date 1998-07-27
Inactive: Approved for allowance (AFA) 1998-06-17
Request for Examination Requirements Determined Compliant 1996-08-30
All Requirements for Examination Determined Compliant 1996-08-30
Application Published (Open to Public Inspection) 1991-04-10

Abandonment History

Abandonment Date Reason Reinstatement Date
1999-10-12
1999-02-01

Maintenance Fee

The last payment was received on 1998-08-24

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
MF (application, 8th anniv.) - standard 08 1997-10-10 1997-09-16
MF (application, 9th anniv.) - standard 09 1998-10-13 1998-08-24
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
AMERICAN HOME PRODUCTS CORPORATION
Past Owners on Record
PETER MAYER
STANLEY F. BARSHAY
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 1991-04-10 1 15
Abstract 1991-04-10 1 9
Claims 1991-04-10 1 19
Drawings 1991-04-10 1 45
Representative Drawing 1991-04-10 1 11
Descriptions 1991-04-10 4 111
Commissioner's Notice - Application Found Allowable 1998-07-31 1 166
Courtesy - Abandonment Letter (NOA) 1999-04-26 1 172
Courtesy - Abandonment Letter (Maintenance Fee) 1999-11-09 1 184
Fees 1998-08-24 1 43
Fees 1997-09-16 1 33
Fees 1992-08-14 1 28
Fees 1991-08-28 1 26
Fees 1993-07-19 1 31
Fees 1994-09-06 1 35
Fees 1995-09-20 1 36
Fees 1996-08-30 1 35